Cel-Sci Corporation (CVM)
CVM moved a median of -0.54% 30 minutes after news, and -0.68% by the close. How CVM actually reacts to news — the realized, point-in-time move the market made, measured across 224 labeled events over the last three years with zero look-ahead.
CVM’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | -0.03% | 40% | 221 |
| 30-min | -0.54% | 37% | 223 |
| 60-min | -0.54% | 40% | 224 |
| to close | -0.68% | 44% | 223 |
| Middle 50% of CVM reactions | -2.87% to +1.43% |
|---|---|
| Median reaction (30-min) | -0.54% |
| Measured reactions | 224 |
Half of all Cel-Sci Corporation news events land between -2.87% and +1.43% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when CVM moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to CVM's baseline. Nothing else.
Recent CVM events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| CEL-SCI Invited to Deliver Keynote Address on Multikine at 6th World Congress on Otology, Rhinology and Laryngology | Press release | Business Wire | -0.65% | -3.27% | |
| Form S-8 CEL SCI CORP | SEC filing · Form S-8 | SEC EDGAR | +1.24% | +1.24% | |
| CEL-SCI Reports Fiscal Third Quarter 2026 Results | Press release | Business Wire | -2.19% | -3.13% | |
| Form 8-K CEL SCI CORP For: Aug 14 | SEC filing · Form 8-K | SEC EDGAR | -2.19% | -3.13% | |
| Form 10-Q CEL SCI CORP For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -2.19% | -3.13% | |
| CEL-SCI Study Published in Peer-Reviewed Oral Oncology Supports Multikine's Biomarker Strategy and Potential Overall Survival Benefit Ahead of Head and Neck Cancer Confirmatory Registration Study | Press release | Business Wire | +4.22% | +8.80% | |
| Leading Oncology Journal Accepts For Publication New CEL-SCI Multikine Phase 3 Data Demonstrating Overall Survival Benefit in Underserved Head and Neck Cancer Patients | Press release | Business Wire | +1.56% | +6.09% | |
| CEL-SCI to Launch FDA Registration-Enabling Phase 3 Confirmatory Study to Bring Multikine® to Market for Newly Diagnosed Head and Neck Cancer | Press release | Business Wire | -5.07% | -11.59% | |
| Form ARS CEL SCI CORP For: Sep 30 | SEC filing · Form ARS | SEC EDGAR | -0.83% | +10.44% | |
| Form DEF 14A CEL SCI CORP For: Jun 23 | SEC filing · Form DEF | SEC EDGAR | -0.83% | +10.44% | |
| CEL-SCI and Saudi Amarox Hold Strategic Agreement Signing Ceremony at BIO 2026, Advancing U.S.–Saudi Cooperation in Cancer Care | Press release | Business Wire | +0.00% | -3.40% | |
| CEL-SCI Advances Multikine® Immunotherapy for Head and Neck Cancer Through Dual U.S. Registration Study and Saudi Market Entry Strategy | Press release | Business Wire | -0.98% | -0.98% | |
| CEL-SCI Announces Closing of Offering | Press release | Business Wire | -1.96% | +7.84% | |
| Form 8-K CEL SCI CORP For: Jun 14 | SEC filing · Form 8-K | SEC EDGAR | -1.96% | +7.84% | |
| CEL-SCI Corporation Announces Pricing of Offering | Press release | Business Wire | +0.00% | -0.98% | |
| CEL-SCI and Saudi Amarox to Conduct Signing Ceremony at BIO 2026 for Strategic Agreement to Advance Commercialization and Distribution of Multikine® in Saudi Arabia | Press release | Business Wire | -2.17% | -6.09% | |
| Form RW CEL SCI CORP | SEC filing · Form RW | SEC EDGAR | -0.34% | +2.07% | |
| Form RW CEL SCI CORP | SEC filing · Form RW | SEC EDGAR | +3.43% | -9.14% | |
| CEL-SCI Reports Fiscal Second Quarter 2026 Results | Press release | Business Wire | +0.00% | +15.44% | |
| Form 10-Q CEL SCI CORP For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +15.44% | |
| Form 8-K CEL SCI CORP For: May 11 | SEC filing · Form 8-K | SEC EDGAR | +5.47% | +11.72% | |
| CEL-SCI Announces Closing of Public Offering | Press release | Business Wire | -1.62% | -1.64% | |
| Form 8-K CEL SCI CORP For: May 11 | SEC filing · Form 8-K | SEC EDGAR | -3.15% | +2.36% | |
| Form EFFECT CEL SCI CORP | SEC filing · Form EFFECT | SEC EDGAR | -4.81% | +14.42% | |
| CEL-SCI Corporation Announces Pricing of Public Offering | Press release | Business Wire | -4.81% | +14.42% | |
| CEL-SCI Enters Strategic Agreement with Amarox for the Registration, Commercialization, and Distribution of Multikine in Saudi Arabia | Press release | Business Wire | -2.87% | -18.97% | |
| Form S-1/A CEL SCI CORP | SEC filing · Form S-1 | SEC EDGAR | -10.19% | -21.76% | |
| Form DEL AM CEL SCI CORP | SEC filing · Form DEL | SEC EDGAR | +0.62% | +1.56% | |
| Form S-1 CEL SCI CORP | SEC filing · Form S-1 | SEC EDGAR | +0.12% | -5.06% | |
| CEL-SCI Reports Fiscal First Quarter 2026 Results | Press release | Business Wire | +0.00% | +7.25% | |
| Form 10-Q CEL SCI CORP For: Dec 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +7.25% | |
| CEL-SCI Reports Fiscal 2025 Results | Press release | Business Wire | +4.13% | +9.96% | |
| Form 10-K CEL SCI CORP For: Sep 30 | SEC filing · Form 10-K | SEC EDGAR | +4.13% | +9.96% | |
| Form EFFECT CEL SCI CORP | SEC filing · Form EFFECT | SEC EDGAR | +0.52% | +8.45% | |
| Form 8-K CEL SCI CORP For: Nov 18 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.15% | |
| Form S-3 CEL SCI CORP | SEC filing · Form S-3 | SEC EDGAR | +1.71% | +2.71% | |
| Form 8-K CEL SCI CORP For: Oct 30 | SEC filing · Form 8-K | SEC EDGAR | -1.39% | -7.78% | |
| CEL-SCI Announces Closing of $10 Million Public Offering | Press release | Business Wire | +0.30% | +4.72% | |
| Form 8-K CEL SCI CORP For: Aug 27 | SEC filing · Form 8-K | SEC EDGAR | -0.10% | +5.35% | |
| Form S-8 CEL SCI CORP | SEC filing · Form S-8 | SEC EDGAR | +1.51% | +14.82% | |
| CEL-SCI Announces Pricing of $10 Million Public Offering | Press release | Business Wire | -0.67% | +3.33% | |
| CEL-SCI Announces Proposed Public Offering | Press release | Business Wire | -0.67% | +3.33% | |
| Form 8-K CEL SCI CORP For: Aug 22 | SEC filing · Form 8-K | SEC EDGAR | +2.79% | +10.00% | |
| CEL-SCI Reports Fiscal Third Quarter 2025 Financial Results | Press release | Business Wire | +0.36% | +4.63% | |
| Form 10-Q CEL SCI CORP For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +2.87% | +1.50% | |
| CEL-SCI’s Multikine Head and Neck Cancer Immunotherapy Breakthrough Medicine Designation Filed in Saudi Arabia: Allows for Patient Access and Reimbursement/Sale Upon Granting of the Designation Which Takes Approximately 60 Days Based on SFDA Timeline | Press release | Business Wire | +2.21% | +8.72% | |
| Form EFFECT CEL SCI CORP | SEC filing · Form EFFECT | SEC EDGAR | +2.21% | +8.72% | |
| Form S-3/A CEL SCI CORP | SEC filing · Form S-3 | SEC EDGAR | +0.92% | +4.58% | |
| CEL-SCI Announces Closing of $5.7 Million Offering Priced At-The-Market Under NYSE American Rules | Press release | Business Wire | -6.30% | -3.02% | |
| Form 8-K CEL SCI CORP For: Jul 11 | SEC filing · Form 8-K | SEC EDGAR | -6.30% | -3.02% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the CVM section they belong to.
Where else CVM is measured.
CVM earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Y-mAbs Therapeutics, Inc. (YMAB) | 226 | -0.20% | 39% |
| Aurinia Pharmaceuticals Inc - Common Shares (AUPH) | 224 | +0.13% | 54% |
| OraSure Technologies, Inc. (OSUR) | 224 | -0.17% | 45% |
| Phibro Animal Health Corporation - Class A (PAHC) | 224 | -0.22% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Cel-Sci Corporation's median reaction calculated?
Every labeled CVM news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 224 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 37% of CVM's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does CVM's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.